Review finds no evidence supporting CDC changes to newborn hepatitis B vaccine guidelines; universal birth dose remains the safest strategy.
Please provide your email address to receive an email when new articles are posted on . Among patients with low baseline HBsAg, 39% achieved HBsAg loss with tobevibart/elebsiran, which rose to 46% ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Up to 19% of patients who received JNJ-3989 achieved ...
If a doctor suspects that a person may have hepatitis B, they will likely order a single blood test to check for the condition. This test is called a hepatitis B titer panel, and it consists of three ...
Reactivation of hepatitis B virus (HBV) infection is a well-recognized complication in cancer patients with chronic HBV (hepatitis B surface antigen [HBsAg] positive) undergoing cytotoxic chemotherapy ...
Aligos Belgium presented research on ALG-005398, a first representative of a series of non-heteroaryldihydropyrimidines (HAPs) class I capsid-assembly modulators, that was identified using ...
Hepatitis B virus is often silently undiagnosed, with only 10.5% of all people estimated to be living with Hepatitis B aware of their condition. Abbott has launched the HBsAg Next Qualitative Assay ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results